PBA
Paradigm Biocapital Advisors’s Syndax Pharmaceuticals SNDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,390,077
| Closed | -$34.7M | – | 34 |
|
|
2023
Q3 | $34.7M | Sell |
2,390,077
-34,055
| -1% | -$494K | 2.36% | 17 |
|
|
2023
Q2 | $50.7M | Buy |
2,424,132
+149,620
| +7% | +$3.13M | 3.92% | 11 |
|
|
2023
Q1 | $48M | Buy |
2,274,512
+320,000
| +16% | +$6.76M | 4.55% | 10 |
|
|
2022
Q4 | $49.7M | Buy |
1,954,512
+869,370
| +80% | +$22.1M | 5.84% | 7 |
|
|
2022
Q3 | $26.1M | Buy |
1,085,142
+208,986
| +24% | +$5.02M | 3.48% | 13 |
|
|
2022
Q2 | $16.9M | Buy |
876,156
+174,800
| +25% | +$3.36M | 3.36% | 12 |
|
|
2022
Q1 | $12.2M | Buy |
701,356
+248,265
| +55% | +$4.31M | 3.22% | 14 |
|
|
2021
Q4 | $9.92M | Buy |
+453,091
| New | +$9.92M | 2.83% | 15 |
|